AlphAIAlphAI — Financial news for AI agents
rttnews.comSEP 302 min read$CAG

Conagra Brands Q1 Profit Rises, Sales Down; Confirms FY27 View; Shares Drop

Conagra Brands reported Q1 profit growth but lower sales, particularly in Grocery & Snacks and Refrigerated & Frozen segments. The company maintained its FY27 outlook, expecting adjusted EPS of $1.40-$1.50 and adjusted operating margin of 10.0%-10.5%. Shares dropped 2.55% in premarket trading. Q1 earnings were $174.3M, up 6% YoY, with net sales down 1.4% to $2.596B.

Original reporting
rttnews.com
Published Sep 30, 2026, 12:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Conagra Brands Q1 Profit Rises, Sales Down; Confirms FY27 View; Shares Drop — source image
Source · rttnews.com
Decision brief

The 30-second read

$CAGBearishHigh
01

Why it matters

The earnings release provides fresh guidance and a modest pre‑market price decline, offering traders a clear entry/exit point.

02

Market read

First‑report earnings with new numbers and guidance; material for traders in consumer staples.

03

What to watch

International segment growth (+2.7%) and foodservice sales (+3.2%) may offset domestic weakness over the longer term.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Conagra Brands (CAG) is a major U.S. packaged‑foods company. The article reports its first‑quarter 2026 earnings and outlook for fiscal 2027.

Company-level read

Ticker impact

$CAGBearishHigh confidence
Context

Conagra Brands reported Q1 profit up 6% to $174.3M, sales down 1.4%, reaffirmed FY27 guidance; shares fell 2.55% pre‑market.

Expected impact

likely pressure as investors digest sales decline and modest guidance reaffirmation

Evidence & confidence

Earnings beat on profit but revenue miss and guidance reaffirmation typically trigger short‑term sell‑off, reflected in the 2.55% pre‑market drop.

Market effects

Sector

Packaged foods sector may see modest weakness as Conagra's sales decline signals broader consumer spending pressure.

Regional

U.S. consumer staples index could face slight drag from Conagra's miss.

Global

Limited; impact confined to U.S. consumer‑goods investors.

Counterpoint

What could challenge this read

Despite sales softness, profit beat and stable guidance could support a short‑term bounce if investors focus on margin improvement.

Key entities

  • Executive
    John Brase

    President and CEO of Conagra Brands, quoted on earnings and outlook.

Read at source← All news

Also covered by

3 outlets

Related articles

SEP 30
$CAGMedAI 8/10

Conagra earnings analysis: questions answered and next catalysts

Conagra Brands (CAG) reported a 46.4% EPS surprise for FY2027 Q1, yet shares fell 3.72% to $13.61. Revenue was in line at $2.60B. Management reiterated free cash flow targets and guided net leverage toward 4.0x, while cutting the dividend. Project Catalyst, an AI-driven cost-reduction initiative, is being funded by increased CapEx. Key uncertainties remain around volume elasticity and private label competition.

investing.com2 min
SEP 30
$CAGMedAI 8/10

Conagra Q1 FY27 slides: EPS beats as volumes decline, shares fall

Conagra Brands (CAG) reported Q1 FY27 adjusted EPS of $0.41, beating estimates by $0.13, but shares fell 5.1% due to volume declines and margin pressures. Organic net sales dropped 1.1% to $2.59B, with volume down 2.1%. Foodservice grew 3.3%, while other segments declined. Management reaffirmed FY27 guidance, expecting organic sales to fall 3% to 1% and adjusted EPS of $1.40 to $1.50.

uk.investing.com3 min
SEP 30
$MDBMed

Market movers: HPE, Boeing, Salesforce, Tiziana Life

MongoDB (MDB) raised long-term growth targets, with Bank of America maintaining a Buy rating. Tiziana Life Sciences (TLSA) seeks FDA orphan drug designation for foralumab. Apple (AAPL) plans a Siri-powered smart-home hub. Salesforce (CRM) acquired Listen Labs, shares up 3.2%. Boeing (BA) won a multi-billion-dollar Navy contract. Conagra (CAG) shares fell 4.6% after Q1 revenue decline. HPE (HPE) shares rose 5% after a $1.2B order from Vultr.

proactiveinvestors.com3 min
SEP 30
$CAGHighAI 8/10

Earnings call transcript: Conagra beats Q1 2026 profit estimates but shares fall

Conagra Brands reported fiscal Q1 2027 earnings of $0.41 per share, beating estimates of $0.28, on revenue of $2.6 billion. Despite the beat, shares fell 2.76% premarket, likely due to margin pressure, higher inflation, and elevated leverage. Management kept full-year guidance unchanged but warned of Q2 margin compression and inflation nearing the high end of its 5-6% range. The company plans to reduce debt by $250 million in fiscal 2027.

uk.investing.com3 min
SEP 30
$CAGHighAI 8/10

Full Transcript: Conagra Brands Q1 2027 Earnings Call - Conagra Brands (NYSE:CAG)

Conagra Brands (NYSE:CAG) reported Q1 earnings beat due to favorable SG&A timing, Ardent Mills benefit, lower inflation, and a tariff refund. Q2 organic sales expected to decline 2% due to cautious elasticity assumptions and Thanksgiving timing. Inflation guidance adjusted to higher end of 5-6% due to increased logistics costs. Company targets long-term leverage goal of three times, plans to pay down $250 million in debt this year, and increase A&P spending to 3% of net sales.

benzinga.com2 min
SEP 30
$CAGHighAI 8/10

Conagra Brands Q1 FY2027 earnings beat Wall Street estimates

Conagra Brands reported Q1 FY2027 net sales of $2.60B, down 1.4% YoY but beating estimates. EPS rose 5.9% to 36 cents. Organic sales fell 1.1%, with volume declines partially offset by pricing. Foodservice sales grew 3.2%, while other segments saw declines. The company maintained its FY2027 outlook, expecting organic sales to fall 1-3% and adjusted EPS to be $1.40-$1.50.

qz.com2 min